Novavax lays off 25% of workforce, releases 2023 outlook
Novavax said on Tuesday it will reduce its global workforce by 25% as the cash-strapped biotech pushes forward with its plans to slash expenses and navigate tepid demand for its COVID-19 vaccines.The company, which had earlier flagged…